FREE MEMBERSHIP Includes » ABL Advisor eNews + iData Blasts | JOIN NOW ABLAdvisor Gray ABLAdvisor Blue
 
Skip Navigation LinksHome / ...

ABL Advisor Search Results

News Stories (68 Results) - Pharmaceuticals

Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, announced that it has entered into credit and... Read Story

July 19, 2017, 07:00 AM

Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it has entered into a $50 million senior... Read Story

July 17, 2017, 07:17 AM

Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $15 million credit facility to new client Unum Therapeutics, a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many... Read Story

March 15, 2017, 07:39 AM

BioDelivery Sciences International, Inc. announced that it has entered into a senior credit facility with affiliates of CRG LP, a healthcare-focused investment firm, to retire its existing credit facility and provide additional working capital for... Read Story

February 24, 2017, 07:25 AM

Eagle Pharmaceuticals, Inc., announced it has entered into a Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto. The Credit Agreement provides for a three-year $50 million revolving credit facility... Read Story

February 01, 2017, 07:18 AM

Endoceutics, Inc., a private Quebec City based biopharma company, announced that it has entered into a long-term $85 million senior credit facility with CRG LP, a healthcare-focused investment firm. The proceeds will support the commercial launch of... Read Story

January 12, 2017, 07:15 AM

Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it closed its previously announced $35... Read Story

January 03, 2017, 07:15 AM

Sorrento Therapeutics, Inc., an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announces it has entered into a loan and security agreement with Hercules Capital, Inc. for... Read Story

November 29, 2016, 07:23 AM

ESSA Pharma Inc., a pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer, announced that it has secured a US$10 million growth capital term loan facility from Silicon Valley Bank ("SVB" or the... Read Story

November 22, 2016, 07:22 AM

Horizon Technology Finance Corporation announced that Horizon and Silicon Valley Bank (“SVB”), have provided a $25 million venture loan facility for vTv Therapeutics Inc., a clinical-stage biopharmaceutical company committed to the discovery and... Read Story

November 16, 2016, 07:22 AM

Omeros Corporation has entered into a senior credit facility with CRG LP, a healthcare-focused investment firm, to retire the company’s existing credit facility, minimizing restricted cash requirements and providing additional working capital for its... Read Story

October 28, 2016, 07:06 AM

Monroe Capital announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor, Linden Capital Partners. Founded in 2001 and based in... Read Story

October 06, 2016, 07:21 AM

BioCryst Pharmaceuticals, Inc. has closed a $23 million senior credit facility with MidCap Financial. The facility was fully funded at closing and bears a variable interest rate based upon LIBOR, currently at 8.5%; an interest-only period through... Read Story

September 26, 2016, 08:11 AM

Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $10 million credit facility to new client Zavante Therapeutics, a clinical-stage biotechnology company. Proceeds from the facility will provide growth capital to... Read Story

September 01, 2016, 07:25 AM

Aprecia Pharmaceuticals Company, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing... Read Story

July 06, 2016, 07:46 AM

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has entered into a $140 million debt facility agreement with CRG LP to retire an existing debt... Read Story

July 01, 2016, 07:21 AM

ANI Pharmaceuticals, Inc. announced that it has entered a new three-year senior secured asset-based revolving credit facility for up to $30 million. This facility will be secured by inventory and certain other working capital and related assets of... Read Story

May 16, 2016, 08:02 AM

Neos Therapeutics, Inc., a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of attention-deficit/hyperactivity disorder (ADHD),announced the closing of a $60 million term... Read Story

May 16, 2016, 07:13 AM

Relypsa, Inc., a biopharmaceutical company, today announced the closing of $150 million in aggregate principal amount of senior secured term loans (the "Loans"), led by funds advised by Athyrium Capital Management and joined by HealthCare Royalty... Read Story

May 04, 2016, 07:22 AM

Oxford Finance announced the closing of a senior credit facility with Diversis Capital, LLC, a private equity firm focused on acquiring and growing small- and middle-market companies. Oxford was the sole lender and administrative agent for this... Read Story

April 26, 2016, 07:47 AM

CIT Group announced that CIT Healthcare Finance served as lead arranger for a $190 million senior secured credit facility to help finance the combination of Vertical/Trigen Holdings, LLC (Vertical/Trigen) with Osmotica Holdings Corp Limited... Read Story

February 12, 2016, 07:28 AM

CytRx Corporation, a biopharmaceutical research and development company specializing in oncology,  has entered into a long-term loan and security agreement with Hercules Technology Growth Capital, Inc. and Hercules Technology III, L.P. for up to $40... Read Story

February 09, 2016, 07:27 AM

Thompson Street Capital Partners (TSCP), in partnership with Arsenal Capital Partners, a New York City-based management and investment firm, announced today that they have recapitalized BioreclamationIVT. The new partnership will provide additional... Read Story

January 20, 2016, 07:09 AM

Acorda Therapeutics, Inc. entered into an agreement to acquire Biotie Therapies Corp. for €23.5680 per ADS in cash, or the equivalent of $25.60 per ADS based on an exchange rate of 1.0864 U.S. dollars to euros, which values Biotie at approximately... Read Story

January 19, 2016, 08:06 AM

NXT Capital announced that it has provided a senior secured credit facility to refinance WellSpring Pharmaceutical Corporation. WellSpring is a portfolio company of Sentinel Capital Partners and Ancor Capital Partners. The transaction included... Read Story

January 05, 2016, 08:13 AM

Pernix Therapeutics Holdings, a specialty pharmaceutical company, today announced the completion of a new three-year $50 million revolving credit facility with Wells Fargo. The new facility bears an interest rate of LIBOR plus 1.5% to LIBOR plus 2.0%... Read Story

August 25, 2015, 07:19 AM

Flexion Therapeutics, Inc. entered into a syndicated senior secured term loan facility with MidCap Financial and Silicon Valley Bank that allows Flexion to borrow up to $30 million at an annual interest rate of 6.25 percent with a maturity of... Read Story

August 05, 2015, 07:28 AM

Ocera Therapeutics secured a $20 million debt facility from Oxford Finance and Silicon Valley Bank (SVB). Ocera intends to use the additional capital to support the ongoing development of the company's novel molecule OCR-002 to treat acute and... Read Story

July 31, 2015, 07:31 AM

Zosano Pharma Corporation has secured $15.0 million in debt financing through Hercules Technology Growth Capital, Inc. Zosano amended its existing secured-term loan facility with Hercules to increase the total loan amount to $15.0 million, with an... Read Story

June 30, 2015, 07:10 AM

ADMA Biologics, Inc., a late-stage biopharmaceutical company developing specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it has entered into a loan and security agreement with Oxford... Read Story

June 22, 2015, 07:16 AM

BioDelivery Sciences International, Inc. has secured an additional $20.7 million in gross debt funding from MidCap Financial to bring BDSI's total outstanding debt with MidCap to $30 million in a single senior secured loan. The proceeds of the loan... Read Story

June 01, 2015, 07:41 AM

Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of a $5 million expansion to an existing $10 million senior secured term loan agreement with Edgemont... Read Story

May 01, 2015, 07:26 AM

Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a $14.5 million senior credit facility to support the recapitalization and growth of Precision Toxicology, LLC by private equity sponsor, BelHealth... Read Story

April 01, 2015, 07:31 AM

Depomed, Inc. has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575 million.  The proceeds of the loan will be used to fund the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen... Read Story

March 13, 2015, 07:21 AM

Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that it has entered into a loan and security agreement with Hercules... Read Story

February 25, 2015, 07:10 AM

GE Capital’s Healthcare Financial Services (HFS) business announced today that it is serving as administrative agent and collateral agent on a $250 million term loan financing for Amneal Pharmaceuticals LLC. This term loan will be pari passu with a... Read Story

February 11, 2015, 07:13 AM

Trevi Therapeutics, Inc., a late-stage clinical development company focused on developing Nalbuphine ER for chronic pruritus conditions, announced the closing of a $15 million senior secured term loan agreement provided by Solar Capital Ltd. as... Read Story

January 09, 2015, 07:24 AM

Dynavax Technologies Corporation announced that the company has entered into a credit facility with Hercules Technology Growth Capital, Inc. for up to $40 million of total funding. Dynavax drew the first tranche of $10 million on closing and has... Read Story

December 29, 2014, 07:52 AM

Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that it has closed on a private... Read Story

December 29, 2014, 07:24 AM

ScripsAmerica, Inc. announced that the company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off... Read Story

December 11, 2014, 07:41 AM

MidCap Financial served as joint lead arranger, joint bookrunner and syndication agent for a $65 million senior secured credit facility in support of the acquisition of Celerion, Inc. by MTS Health Investors, LLC ("MTS").MidCap's Leveraged Loan &... Read Story

November 18, 2014, 08:01 AM

BMO Harris Bank’s Sponsor Finance group announced it was joint lead arranger, joint bookrunner and administrative agent for $65 million in senior secured credit facilities to Celerion, Inc., an MTS Health Investors portfolio company Celerion is a... Read Story

November 04, 2014, 07:29 AM

Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that it... Read Story

October 01, 2014, 06:57 AM

PharMerica Corporation, a national provider of institutional specialty home infusion hospital and oncology pharmacy services, announced that it has successfully closed on a new credit agreement. PharMerica will use the facilities for general... Read Story

September 22, 2014, 07:54 AM

Trevena, Inc. has entered into a senior secured term loan credit facility providing for up to $35 million of funding, of which $2 million was drawn at closing. Trevena has the option to draw the remaining funds in two equal tranches upon positive... Read Story

September 22, 2014, 07:49 AM

Cardiome Pharma Corp. announced today the closing of a senior, secured term loan facility of up to $22 million to be made available to the company by MidCap Financial, LLC in two tranches with an interest rate of Libor plus 8%.Cardiome currently... Read Story

July 21, 2014, 07:28 AM

ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced that it has secured a debt facility of up to $20 million with MidCap Financial. The company will use the... Read Story

July 18, 2014, 07:49 AM

DURECT Corporation announced that it had entered into a Loan and Security Agreement (the "Loan Agreement") with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the company in the principal amount of $20 million. The loan... Read Story

June 27, 2014, 07:11 AM

Horizon Pharma, Inc. announced that it has entered into an agreement with a group of lenders to provide Horizon with $300 million in financing through a five year senior secured credit facility. Funding is expected to occur coincident with the... Read Story

June 19, 2014, 07:33 AM

RuiYi, Inc., a global therapeutic innovation leader, announced the close of a $4 million debt financing from Silicon Valley Bank to advance a pipeline of novel monoclonal antibodies (mAb) targeting G protein coupled receptors (GPCRs). RuiYi plans to... Read Story

June 12, 2014, 07:21 AM

Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, announced that it has secured a $4.5 million term loan agreement with Square 1 Bank. In advance of this transaction, Evoke repaid the... Read Story

May 29, 2014, 07:19 AM

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that its United Kingdom subsidiary, Alimera Sciences Limited (Limited)... Read Story

April 25, 2014, 07:10 AM

Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million term loan with with Zafgen, Inc. The funds were provided to Zafgen from... Read Story

April 18, 2014, 07:10 AM

Concordia Healthcare Corp. has entered into a definitive agreement to acquire Donnatal, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis, from a privately held specialty pharmaceutical company... Read Story

March 21, 2014, 07:34 AM

Omeros Corporation closed a senior credit facility with Oxford Finance and MidCap Financial consisting of a $32 million term loan, which requires interest-only payments through March 2015. Thereafter, monthly principal and interest payments will be... Read Story

March 06, 2014, 07:14 AM

ADMA Biologics, Inc. announced it has secured a loan commitment for up to $15 million from Hercules Technology Growth Capital, Inc., a leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in... Read Story

February 28, 2014, 07:19 AM

Pernix Therapeutics Holdings, Inc. announced that it has closed on the issuance of $65 million aggregate principal amount of 8.00% Convertible Senior Notes due 2019 (the “Notes”) to a group of institutional investors led by Athyrium Capital... Read Story

February 26, 2014, 07:05 AM

On January 23, 2014, Jazz Pharmaceuticals, as guarantor, and three of its wholly-owned subsidiaries, Jazz Pharmaceuticals, Inc. (the "U.S. Borrower"), Jazz Financing I Limited and Jazz Pharmaceuticals Ireland Limited, as borrowers (collectively with... Read Story

January 24, 2014, 07:07 AM

Acura Pharmaceuticals, Inc. entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million. The loan has a fixed interest rate of 8.35%... Read Story

December 31, 2013, 07:56 AM

Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has completed a $25 million long-term debt financing with a lending syndicate consisting of MidCap Financial, LLC, Oxford Finance LLC, and... Read Story

December 30, 2013, 08:04 AM

AcelRx Pharmaceuticals has entered into a new amended and restated credit facility with Hercules Technology Growth Capital, Inc. that extends AcelRx's current relationship with Hercules, which was established in June 2011. The new Hercules credit... Read Story

December 20, 2013, 07:19 AM

Lannett Company, Inc. has established a new, five-year $50 million revolving credit facility with a syndicate of two lenders, Citibank, N.A., as administrative agent, and PNC Bank, National Association. Lannett expects to use the credit facility for... Read Story

December 20, 2013, 07:13 AM

Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the company has entered into a $75 million debt facility agreement with an affiliate of OrbiMed Advisors LLC to... Read Story

November 22, 2013, 07:23 AM

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, entered into an Incremental Assumption Agreement ("Incremental Agreement") with Morgan Stanley Senior Funding, Inc. ("MSSF") under its existing Credit Agreement with MSSF.  Under... Read Story

September 20, 2013, 07:16 AM

Akorn Inc., a maker of generic eye-care products, obtained $675 million of financing commitments backing its purchase of Hi-Tech Pharmacal Co. The credit pact consists of a $600 million term loan and a $75 million revolving credit line, according to... Read Story

August 29, 2013, 07:48 AM

Prospect Capital Corporation has provided $80.0 million of floating-rate first-lien senior-secured loans and a senior-secured revolving credit facility for the recapitalization of Matrixx Initiatives, Inc., owner of Zicam, a leading developer and... Read Story

August 12, 2013, 07:31 AM

Cole Taylor Business Capital, a division of Cole Taylor Bank, recently announced the funding of a $12 million facility for PureTek Corporation. The company, located in San Fernando, CA, is a manufacturer and distributor of pharmaceuticals... Read Story

July 10, 2013, 07:09 AM

Anthera Pharmaceuticals, a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, secured a new $20.0 million debt financing facility through a syndicate led by MidCap Financial. Anthera will use the loan... Read Story

April 08, 2013, 07:46 AM